CROS NT designs studies in a way that can expedite submissions and streamline the route to more efficient and effective solutions. Depth of experience allows for precision pair technology and proven processes with client oncology studies—from small phase I trials to large Phase III-IV multinational studies.
 
The extensive knowledge of the CROS NT project management, statistics and data management team has resulted in over 10,000 patients involved in Phase I-IV oncology clinical trials across multiple indications such as:

CROS NT reduces a project’s duration, the need for retraining and increases the quality of service by applying previously established templates and communication pathways. Assigning a dedicated, experienced project manager to each study ensures that Sponsors will reach their specific goals.

Speed Up the Planning Phase
CROS NT’s previous experience enables a reduction of time from the first study synopsis to first patient in the study. Our statistical team offers support in defining adequate target criteria (i.e. time to progression, overall survival time, response rates), planning interim analysis, or specifying the most efficient statistical method for analysis.

Standardize the Information
Standardization, meaning establishing uniform technical specifications, criteria, methods, processes or practices, allows the possibility to use disease staging, adverse effects documentation, QoL questionnaires, and follow-up information. Using these specific forms, it is possible to improve quality and reduce project cost through a validated database structure, validated SDTM and AdaM format or ePRO solutions.

Optimize the Output
Optimizing means establishing criteria, methods, processes or practices for presenting results. These include creating tables for submission to DSMB, tables and figures of statistical analysis and generating exploratory analysis.